Inventiva S.a. cash flow statement
In fiscal 2025, Inventiva S.a.'s operations generated −$119m of cash.
Cash flow statement
Compare with peers
- Adlai Nortye Group Ltd. cash flow
- Immuron Ltd cash flow
- Rani Therapeutics Holdings, Inc. cash flow
- Bolt Biotherapeutics, Inc. cash flow
- Entrada Therapeutics, Inc. cash flow
Head to head: ANL vs IVAIMRN vs IVAIVA vs RANI
More: Biotechnology stocks compared, Health Care sector, rankings of US companies